Three patient deaths linked to gene therapies developed by Sarepta Therapeutics (SRPT) have drawn FDA scrutiny on the viral ...

Amentum's strong execution, contract wins with the DoD, and deleveraging plans drive growth. Find out why I find AMTM ...

Cal-Maine Foods thrives with zero debt and diversification efforts. Discover its long-term potential despite egg price ...

Super Micro Computer leverages AI demand and innovative cooling tech but faces margin pressures. Read why there are better ...

Conagra's Q4 results and '26 guidance disappointed, yet valuation offers optimism. Explore potential growth via asset sales ...

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

Bank of America’s preferreds offer strong income security and attractive yields, with low redemption risk and solid coverage.

Neuralink, the neurotechnology company co-founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, has joined a clinical trial aimed ...

Analyzing weekly Wall Street updates with major stock upgrades and downgrades, including Tesla, Netflix, Lockheed Martin, and ...

In two years, BrightSpire Capital (BRSP) will be growing its dividend and seeing strong performance. Read the full analysis ...

Venu Holding faces worsening losses and a complex capital structure that clouds shareholder value despite growth plans. Learn ...

City Office REIT’s shares trade near acquisition values, leaving minimal upside as deal risks outweigh remaining arbitrage.